Clinical Trial Update: A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating Avacopan in participants with ANCA-associated vasculitis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Drugs mentioned

• Avacopan (Tavneos) (avacopan)

Snippet

Sponsor: Amgen | Conditions: Antineutrophil Cytoplasmic Antibody-associated Vasculitis | Phase 4 | Status: RECRUITING